ELAN (Elanco Animal Health) EBIT per Share : $1.45 (TTM As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Elanco Animal Health EBIT per Share?

Elanco Animal Health's EBIT per Share for the three months ended in Dec. 2024 was $-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $1.45.

During the past 12 months, the average EBIT per Share Growth Rate of Elanco Animal Health was -23.70% per year. During the past 3 years, the average EBIT per Share Growth Rate was -6.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Elanco Animal Health's EBIT per Share or its related term are showing as below:

ELAN' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -14.5 Med: -6.8 Max: 305.5
Current: -6.8

During the past 10 years, the highest 3-Year average EBIT per Share Growth Rate of Elanco Animal Health was 305.50% per year. The lowest was -14.50% per year. And the median was -6.80% per year.

ELAN's 3-Year EBIT Growth Rate is ranked worse than
72.9% of 823 companies
in the Drug Manufacturers industry
Industry Median: 7.8 vs ELAN: -6.80

Elanco Animal Health's EBIT for the three months ended in Dec. 2024 was $-5 Mil.

Elanco Animal Health EBIT per Share Historical Data

The historical data trend for Elanco Animal Health's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elanco Animal Health EBIT per Share Chart

Elanco Animal Health Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

-1.19

-0.69

0.35

-1.87

1.45

Elanco Animal Health Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EBIT per Share	Get a 7-Day Free Trial															-0.12	0.16	0.07	1.24	-0.01

Elanco Animal Health EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Elanco Animal Health's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	723	/	497.300
=	1.45

Elanco Animal Health's EBIT per Share for the quarter that ended in Dec. 2024 is calculated as

	EBIT per Share		(Q: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-5	/	498.500
=	-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.45

Elanco Animal Health (NYSE:ELAN) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Elanco Animal Health EBIT per Share Related Terms

Thank you for viewing the detailed overview of Elanco Animal Health's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Elanco Animal Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elanco Animal Health Inc (NYSE:ELAN) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

ELAN:Mexico 5EA:Germany

Address

2500 Innovation Way, Greenfield, IN, USA, 46140

Website

https://www.elanco.com

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

Executives

Lawrence Erik Kurzius	director	18 LOVETON CIRCLE, SPARKS MD 21152
R David Hoover	director	C/O EDGEWELL PERSONAL CARE COMPANY, 1350 TIMBERLAKE MANOR PARKWAY, CHESTERFIELD MO 63017
Michael J Harrington	director	LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Jeffrey N Simmons	director, officer: Pres., Chief Executive Officer	2500 INNOVATION WAY, GREENFIELD IN 46140
William F Doyle	director
Grace Mcardle	officer: EVP, MANUFACTURING AND QUALITY	2500 INNOVATION WAY, GREENFIELD IN 46140
Timothy J Bettington	officer: See remarks	C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
John P Bilbrey	director
Rajeev A. Modi	officer: See Remarks	2500 INNOVATION WAY, GREENFIELD IN 46140
Paul Herendeen	director	C/O BAUSCH HEALTH COMPANIES INC., 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Brabander Ellen De	officer: See Remarks	2500 INNOVATION WAY, GREENFIELD IN 46140
Marcela A. Kirberger	officer: Ex VP, Gen Counsel & Corp Sec	C/O ELANCO ANIMAL HEALTH INCORPORATED, 2500 INNOVATION WAY, GREENFIELD IN 46140
Art A Garcia	director	11690 N.W. 105TH STREET, MIAMI FL 33178
Uncas Gp Llc	director	250 WEST 55TH STREET, 34TH FLOOR, NEW YORK NY 10019
Sachem Head Gp Llc	director	250 WEST 55TH STREET, 34TH FLOOR, NEW YORK NY 10019